We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
You are on page 1/ 34
TUBULO-INTERSTITIAL DISEASES
• The clinical presentation is with
a) tubular dysfunction and b) electrolyte abnormalities, c) moderate proteinuria and d) varying degrees of renal impairment. Acute interstitial nephritis • Acute interstitial nephritis (AIN) may be caused by 1) allergic reactions (e.g. penicillins, NSAIDs), 2) autoimmune nephritis, infections (e.g. pyelonephritis, TB) or 3) toxins (e.g. mushrooms or myeloma light chains). Clinical presentation 1) nonoliguric renal impairment or 2) an eosinophilic reaction with fever and rash. Investigations 1) Urinalysis shows leucocytes and eosinophils in 70% of patients. 2) Renal biopsies show intense inflammation surrounding tubules and blood vessels and invading tubules, with occasional eosinophils (especially in druginduced disease). Continue • Only ~30% of patients with druginduced AIN have a generalised drug hypersensitivity reaction (e.g. fever, rash, eosinophilia). Management a) Remove/treat the cause. b) Steroids may accelerate recovery and prevent longterm scarring. c) Shortterm dialysis is sometimes required. Chronic interstitial nephritis • It is often diagnosed late and has no apparent aetiology. Clinical features • Most patients present in adult life with a) moderate CKD (stage 3), b) hypertension and c) small kidneys d) electrolyte abnormalities (e.g. hyperkalaemia, acidosis) may be severe. • Urinalysis is nonspecific. Causes of chronic interstitial nephritis
1) Acute interstitial nephritis
2) Glomerulonephritis 3) Immune/inflammatory (sarcoid, Sjögren’s, systemic lupus erythematosus) 4) Toxic (mushrooms, Balkan nephropathy, lead) Continue 5) Drugs (ciclosporin, tacrolimus, tenofovir, lithium, analgesics) 6) Infection (severe pyelonephritis) 7) Congenital/developmental (reflux, sicklecell nephropathy) 8) Metabolic and systemic diseases (hypokalaemia, hyperoxaluria) Management • supportive, with correction of electrolyte abnormalities and RRT if required Reflux nephropathy (chronic pyelonephritis)
• This chronic interstitial nephritis is associated
with vesicoureteric reflux (VUR) in early life, and with the appearance of scars in the kidney. Clinical features • Usually the renal scarring and renal/ureteric dilatation are asymptomatic. • Presentation may be at any age, with a) hypertension, b) proteinuria or c) features of CKD. Continue • Frequency, dysuria and lumbar back pain may be present; however, there may be no history of UTIs. • There is an increased prevalence of urinary calculi. Investigations 1) USS: will exclude significant obstruction but is not helpful in identifying renal scarring. Continue 2) Longitudinal CT/MRI: may be useful to assess progression. 3) Radionuclide scans: sensitive but seldom required, as surgery for VUR is uncommon. 4) Urinalysis shows leucocytes and proteinuria (usually < 1 g/24 hrs). Management and prognosis • Treat infection. • If recurrent, use prophylactic therapy. • Nephrectomy is indicated if infection recurs in an abnormal kidney with minimal function. • Hypertension is occasionally cured by the removal of a diseased kidney when disease is unilateral. • Otherwise, surgery is rarely indicated as most childhood reflux disappears spontaneously CYSTIC KIDNEY DISEASES Polycystic kidney disease • Adult polycystic disease (PKD) is a common condition (prevalence ~1 : 1000) that is inherited as an autosomal dominant trait. Small cysts lined by tubular epithelium develop from infancy or childhood and enlarge slowly and irregularly. • Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic cause of chronic kidney disease • Renal failure occurs from recurrent episodes of pyelonephritis and nephrolithiasis Continue • Renal failure is associated with grossly enlarged kidneys. • PKD is not a premalignant condition. Continue • Mutations in PKD1 account for 85% of cases and PKD2 for ~15%. • ESRD occurs in ~50% of patients with PKD1 with a mean age of onset of 52 yrs, but in a minority of patients with PKD2 with a mean age of onset of 69 yrs. • Between 5 and 10% of patients on RRT have adult PKD. Common clinical features a) Asymptomatic until later life b) Vague discomfort in loin or abdomen due to increasing mass of renal tissue c) One or both kidneys palpable, with nodular surface d) Acute loin pain or renal colic due to haemorrhage into a cyst Continue e) Hypertension gradually develops over age 20 yrs f) Haematuria (with little or no proteinuria) g) Urinary tract or cyst infections h) Gradual-onset renal failure Associated features 1) Hepatic cysts (30%) 2) Berry aneurysms of the cerebral vasculature 3) Mitral and aortic regurgitation (common but rarely severe) 4) Colonic diverticula 5) Abdominal wall hernias Management • Good BP control is important because of cardiovascular morbidity and mortality, but there is no evidence that this retards the development of renal failure in PKD. Continue • There is some evidence that the vasopressin V2 receptor antagonist tolvaptan may slow cyst formation but this is not yet established treatment. Continue • Patients with PKD are usually good candidates for dialysis and transplantation. • Sometimes kidneys are so large that one or both have to be removed to make space for a renal transplant. Other cystic diseases Medullary sponge kidney • Characterised by cysts confined to papillary collecting ducts, this disease is not inherited and its cause is unknown. Continue • Patients usually present as adults with renal stones. • These are often recurrent, but the prognosis is generally good. • The diagnosis is made by USS or intravenous urography (IVU). • Contrast medium is seen to fill dilated or cystic tubules, which are sometimes calcified Acquired cystic disease • Patients with a very long history of renal failure (and usually on longterm dialysis) often develop multiple renal cysts in their shrunken kidneys • Kidneys are enlarged but not to the size seen in PKD. Continue • Acquired cystic disease is associated with 1) increased erythropoietin production and 2) an increased risk of renal cell carcinoma.